Jesse L. Goodman, MD, MPH is Professor of Medicine and Infectious Diseases and Attending Physician at Georgetown University. He was previously Chief of Infectious Diseases at the University of Minnesota where his laboratory isolated the causative agent of human granulocytic anaplasmosis. From 2003-9 he served as Director of the Center for Biologics Evaluation and Research (CBER), regulating vaccines, blood and cell and gene therapies, and then as Chief Scientist of the US FDA until 2014, serving in the US leadership for numerous public health responses. He is a member of the National Academy of Medicine and ahs served on numerous WHO, CDC, NIH, NAM and other advisory committees. He previously served as an independent member of GSK’s board, chairing its science committee.

John D. Gräbenstein, PhD, is a global vaccinologist, pharmacist, and public-health leader. He served 27 in the U.S. Army Medical Department. As a Colonel, he directed DoD's Military Vaccine Agency. He served for 13 years as Global Executive Director of Medical Affairs for Merck Vaccines. He operates Vaccine Dynamics, a consulting service on vaccinology and has no conflicts of interest. He is a Member of he National Academy of Medicine.

Mary T. Bassett, MD, MPH, directs the Francois-Xavier Bagnoud Center for Health and Human Rights at Harvard University where she is Professor of the Practice of Health and Human Rights in the Harvard T.H. Chan School of Public Health . She previously served as the New York City health commissioner and, later, as the New York State health commissioner. She is a Member of the National Academy of Medicine.

Dr. Norman W. Baylor is the Chair of the Board of Directors of Biologics Consulting Group, Inc., a scientific, regulatory, and clinical consulting firm. He is a member of the Board of Trustees at the Sabin Vaccine Institute and Editor-in-Chief of the Journal of the International Alliance for Biological Standardization (IABS).  Dr. Baylor was previously Director of the Office of Vaccines Research and Review at the US FDA’s Center for Biologics Evaluation and Research. He also served as FDA’s liaison member to the CDC’s Advisory Committee on Immunization Practices (ACIP), the Department of Health and Human Services National Vaccine Advisory Committee, the Advisory Commission on Childhood Vaccines, and the NIH NIAID Council. Dr. Baylor trained as a virologist and received his Ph.D. at the University of Kentucky.

Luciana Borio, MD, is a Venture Partner at ARCH Venture Partners and a Senior Fellow for Global Health at the Council on Foreign Relations. She previously served as Director for Medical and Biodefense Preparedness at the National Security Council and Acting Chief Scientist at the U.S. Food and Drug Administration, where she was closely involved in medical countermeasure development. Dr. Borio trained in internal medicine and infectious diseases. She has served on numerous advisory boards related to pandemic preparedness and vaccine innovation. At ARCH, she is involved in a number of companies focused on medical product development, clinical trials, and other unmet needs.

M. Miles Braun, MD MPH, was Director of the Division of Epidemiology at FDA/CBER 1999-2008, with responsibility for post-approval safety surveillance of vaccines and other biologic products and for consulting on sponsors’ post-approval safety commitments.  He subsequently worked at separate times for three vaccine manufacturers for a total of four years.  Dr. Braun trained in preventive medicine, public health and epidemiology at NIH, CDC and Johns Hopkins and has well over 100 publications in the scientific literature.  He currently is Adjunct Full Professor in the Department of Oncology, Georgetown University School of Medicine, where he directs the Adolescent and Young Adult Integrative Oncology Initiative.

Bruce Gellin, MD, MPH is an infectious diseases physician with a focus on the bridge between science, epidemiology, programs and policies in US and globally. He is currently an Adjunct Professor of Medicine and Senior Advisor, Global Health Institute, Georgetown University, and serves as a principal for the Vaccine Integrity Project at the Center for Infectious Diseases Research and Policy. He served as an Epidemic Intelligence Service Officer in the Meningitis and Special Pathogens Branch of CDC, and as Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office in the US Department of Health and Human Services. He previously was President, Global Immunization of the Sabin Vaccine Institute and Senior Vice President and Chief, Global Public Health Strategy of the Rockefeller Foundation.

Peter Hotez MD PhD DSc (hon) FAAP FASTMH is Professor of Pediatrics and Molecular Virology and Microbiology at Baylor College of Medicine where he is also Co-Director of the Texas Children’s Hospital Center for Vaccine Development, and Dean of the National School of Tropical Medicine. He is also University Professor of Biology at Baylor University. Dr. Hotez is a vaccine scientist, biochemist, and pediatrician who has led or co-led the development of vaccines for parasitic infections-hookworm, schistosomiasis, Chagas disease-currently in clinical trials, and several coronavirus vaccines, including two low-cost COVID vaccines for global health so far administered to 100 million children and adults in India and Indonesia. He is also an ardent vaccine advocate and science explainer who combats antiscience and antisemitism in America, and globally.

 Philip Krause, M.D., is a virologist and infectious diseases specialist. He is currently an independent consultant and also serves as Chair of WHO COVID Vaccines Research Expert Group. He was formerly Deputy Director of FDA's Office of Vaccines Research and Review.

Glen Nowak, Ph.D., is Associate Dean for Research and Graduate Studies in the College of Journalism and Mass Communication at the University of Georgia (UGA). He is also a professor, specializing in health, risk, and infectious disease communication, and co-directs the College’s Center for Health & Risk Communication. Prior to re-joining the UGA faculty in January 2013, Dr. Nowak spent 14 years at the U.S. Centers for Disease Control and Prevention (CDC), including six years as the Communications Director for the National Immunization Program, six years as the agency’s Director of Media Relations (including during the 2009-10 influenza pandemic), and two years as a senior advisor to the director of the National Center for Immunization and Respiratory Diseases. He is an author or co-author of over 50 peer-reviewed journal articles, ten book chapters, and co-editor of the book Advancing Crisis Communication Effectiveness.

Paul A. Offit, MD is the Director of the Vaccine Education Center at the Children’s Hospital of Philadelphia as well as the Maurice R. Hilleman Professor of Vaccinology and a Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Dr. Offit is currently a voting member on the FDA’s Vaccine Advisory Committee and has previously served on the Advisory Committee for Immunization Practices to the CDC. He is also the co-inventor of the rotavirus vaccine, RotaTeq, recommended for universal use in infants by the CDC in 2006 and by the WHO in 2013. This vaccine was estimated recently to save about 165,000 lives a year.  He is also the author of eleven books written for the public about science, medicine, and vaccines.  

Walter A Orenstein, MD, DSc (Hon) is Professor Emeritus of Medicine, Pediatrics, Epidemiology, and Global Health at Emory University.  He is also the Director of OrensteinVax, LLC, a consulting firm.  Dr. Orenstein worked at the Centers for Disease Control and Prevention (CDC) for 26 years and was the Director of the United States Immunization Program for 16 years (1988-2004).  He has co-edited the standard textbook in Vaccinology, Plotkin’s Vaccines for the last 6 editions.  His work has focused on developing and implementing vaccination policies especially with regard to polio eradication and measles elimination.